Ward Biotech Ltd

Clinically proven, market-leading technology set to launch into the €1.13bn veterinary oral care market to achieve €19MM revenues in 5 years

  • Stage Full Product Ready
  • Industry Other
  • Location Monaghan, Ireland
  • Currency EUR
  • Founded August 2009
  • Employees 5
  • Website wardbiotech.com

Company Summary

We develop innovative new products for the €1.13bn global companion animal oral care market. Pilot trials suggest our technology has market-leading efficacy, to be confirmed by independent clinical trials currently ongoing, and has captured the attention of certain multi-national animal health companies. Ward Biotech aims to launch in the UK market in April 2014.

Team

  • Laura Coyle
    Product Manager

    Laura Coyle has a BSc in Biological Sciences, an MSc in Marketing and 12 years’ SME experience in manufacturing and product development.

  • John Nally
    Finance Manager

    John Nally is a Chartered Global Management Accountant (C.G.M.A) with more than 25 years’ SME experience.

  • Paul Ward
    CEO

    Paul Ward is an entrepreneur with more than 20 years’ experience of the pet care industry having set up and managed a successful business in the supply of ingredients to the pet food industry.

  • Brian English
    Sales Director

    Brian English is an Irish national, living and working in the Netherlands for the past 20 years, where he has built and managed successful routes to market for several international corporations.

Advisors

  • Eversheds
    Lawyer
    Unconfirmed
    PWC
    Accountant
    Unconfirmed
    Dr. Rory Breathnach
    Chief Veterinary Advisor
    Unconfirmed

Previous Investors

  • Board Members €1.55M
    Unconfirmed
    Enterprise Ireland €150K
    Unconfirmed
    Private Investors €918K
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free